E-LIB Suche - Ergebnisse für: Bungey, G.

1

HTA314 A Review of Pediatric Medicines Assessed by NICE Bet..:

Karinou, E. ; Beugre-Guyot, M. ; Bungey, G..
Value in Health. 26 (2023) 12 - p. S381 , 2023

Link: https://doi.org/10.1016/..

2

EE148 Are General Population Utilities Appropriate to Use a..:

Chang-Douglass, S. ; Bungey, G.
Value in Health. 26 (2023) 12 - p. S78-S79 , 2023

Link: https://doi.org/10.1016/..

3

EE29 Clinical and Economic Impact of Pre-Exposure Prophylax..:

Rivolo, S. ; Bungey, G. ; Morris, W....
Value in Health. 26 (2023) 12 - p. S55 , 2023

Link: https://doi.org/10.1016/..

4

EE517 Cost-Effectiveness Analysis of Tafasitamab in Combina..:

Karaiskou, M. ; Avgitidou, A. ; Vostitsanou, Z....
Value in Health. 26 (2023) 12 - p. S151 , 2023

Link: https://doi.org/10.1016/..

5

POSA147 A Review of Methods Used to Estimate Pediatric Util..:

Purushotham, S ; Brown, L ; Francmanis, E...
Value in Health. 25 (2022) 1 - p. S62-S63 , 2022

Link: https://doi.org/10.1016/..

6

MSR36 Modelling of UK General Population Utility: The ALDVM..:

Chang-Douglass, S ; Bungey, G ; Dakin, H
Value in Health. 25 (2022) 12 - p. S356-S357 , 2022

Link: https://doi.org/10.1016/..

7

EE572 Cost-Effectiveness of AZD7442 (Tixagevimab and Cilgav..:

Sutton, K ; Miller, P ; Branscombe, N...
Value in Health. 25 (2022) 12 - p. S168 , 2022

Link: https://doi.org/10.1016/..

8

HSD27 Constrained Optimization Model to Estimate Best Boost..:

Kapoor, R ; Standaert, B ; Nolan, T...
Value in Health. 25 (2022) 12 - p. S278 , 2022

Link: https://doi.org/10.1016/..

9

MSR7 Multiplicative With Linear Transformation (MLT): An Im..:

Bungey, G ; Chang-Douglass, S ; Dakin, H
Value in Health. 25 (2022) 12 - p. S351 , 2022

Link: https://doi.org/10.1016/..

10

POSA262 The Use of Akaike Information Criterion and Bayesia..:

Bungey, G ; Brown, L ; De Boisvilliers, S...
Value in Health. 25 (2022) 1 - p. S171 , 2022

Link: https://doi.org/10.1016/..

11

DMD - TREATMENT:

Iff, J. ; Bungey, G. ; Paine, A....
Neuromuscular Disorders. 31 (2021) - p. S94 , 2021

Link: https://doi.org/10.1016/..

12

PCN179 TREOSULFAN-BASED CONDITIONING VS BUSULFAN-BASED COND..:

Bungey, G. ; Howard, D. ; Leoncini, E.
Value in Health. 22 (2019) - p. S471 , 2019

Link: https://doi.org/10.1016/..

13

Cost-Utility Analysis of Biological Therapies In Psoriasis ..:

Bungey, G ; Chang-Douglass, S ; Erickson, R.
Value in Health. 20 (2017) 9 - p. A556 , 2017

Link: https://doi.org/10.1016/..

14

Economic Evaluation of Subcutaneous Methotrexate For Long-T..:

Bungey, G ; Webb, N ; Price, K.
Value in Health. 20 (2017) 9 - p. A549-A550 , 2017

Link: https://doi.org/10.1016/..

15

Modelling of UK general population utility: the ALDVMM appr..:

Chang-Douglass, S ; Bungey, G ; Dakin, H
doi:10.1016/j.jval.2022.09.1768. , 2023

Link: https://doi.org/10.1016/..